[HTML][HTML] Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study
M Krutikov, O Stirrup, H Nacer-Laidi, B Azmi… - The Lancet Healthy …, 2022 - thelancet.com
Background The SARS-CoV-2 omicron variant (B.1.1.529) is highly transmissible, but disease
severity appears to be reduced compared with previous variants such as alpha and delta. …
severity appears to be reduced compared with previous variants such as alpha and delta. …
[HTML][HTML] Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England …
M Shrotri, M Krutikov, H Nacer-Laidi, B Azmi… - The Lancet Healthy …, 2022 - thelancet.com
Background Residents and staff in long-term care facilities have been prioritised for vaccination
against SARS-CoV-2, but data on potential waning of vaccine effectiveness and the …
against SARS-CoV-2, but data on potential waning of vaccine effectiveness and the …
Clinical effectiveness of SARS-CoV-2 booster vaccine against Omicron infection in residents and staff of Long-Term Care Facilities: a prospective cohort study …
…, NL Adams, M Krutikov, H Nacer-Laidi… - Open Forum …, 2023 - academic.oup.com
Background Successive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants have caused severe disease in long-term care facility (LTCF) residents. Primary …
variants have caused severe disease in long-term care facility (LTCF) residents. Primary …
Severe acute respiratory syndrome coronavirus 2 anti-spike antibody levels following second dose of ChAdOx1 nCov-19 or BNT162b2 vaccine in residents of long …
…, S Hulme, R Giddings, H Nacer-Laidi… - The Journal of …, 2022 - academic.oup.com
General population studies have shown strong humoral response following severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination with subsequent waning of anti-…
respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination with subsequent waning of anti-…
SARS-CoV-2 anti-spike antibody levels following second dose of ChAdOx1 nCov-19 or BNT162b2 in residents of long-term care facilities in England (VIVALDI)
…, U Amin, A Jadir, S Hulme, R Giddings, H Nacer-Laidi… - medRxiv, 2022 - medrxiv.org
Background General population studies have shown strong humoral response following
SARS-CoV-2 vaccination with subsequent waning of anti-spike antibody levels. Vaccine-…
SARS-CoV-2 vaccination with subsequent waning of anti-spike antibody levels. Vaccine-…
Duration of vaccine effectiveness against SARS-CoV2 infection, hospitalisation, and death in residents and staff of Long-Term Care Facilities (VIVALDI): a prospective …
M Shrotri, M Krutikov, H Nacer-Laidi, B Azmi, T Palmer… - medRxiv, 2022 - medrxiv.org
Background Long-term care facilities (LTCF) have been prioritised for vaccination, but data
on potential waning of vaccine effectiveness (VE) and the impact of booster doses in this …
on potential waning of vaccine effectiveness (VE) and the impact of booster doses in this …
Severe outcomes in residents of Long Term Care Facilities following infection with SARS-CoV-2 Omicron variant (VIVALDI study)
M Krutikov, O Stirrup, H Nacer-Laidi, B Azmi, C Fuller… - 2022 - pesquisa.bvsalud.org
… Maria Krutikov; Oliver Stirrup; Hadjer Nacer-Laidi; Borscha Azmi; Chris Fuller; Gokhan Tut;
Tom Palmer; Madhumita Shrotri; Aidan Irwin-Singer; Verity Baynton; - The COVID-19 …
Tom Palmer; Madhumita Shrotri; Aidan Irwin-Singer; Verity Baynton; - The COVID-19 …
An epidemiological investigation of the burden of and facility-level risk factors for SARS-CoV-2 infection and outbreaks in care home staff and residents
M Krutikov - 2023 - discovery.ucl.ac.uk
Background The COVID-19 pandemic significantly impacted care homes, highlighting their
vulnerability to infection. I described the burden of infection and investigated facility-level risk …
vulnerability to infection. I described the burden of infection and investigated facility-level risk …
[HTML][HTML] Review 4:" Outcomes of SARS-CoV-2 Omicron infection in residents of Long-Term Care"
V Auvigne - Rapid Reviews Infectious Diseases, 2022 - rapidreviewscovid19.mitpress.mit …
This preprint examines the mortality and hospitalization rates of the SARS-CoV-2
Omnicronvariant and compares them to the Delta variant. Reviewers found the study reliable but …
Omnicronvariant and compares them to the Delta variant. Reviewers found the study reliable but …